The current classification criteria for APS involve three aPL tests: lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and anti-β2 glycoprotein I antibodies (anti-β2GPI) (1). This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.